{
    "RADCURE-0915": {
        "question": "Age: 75.1, Sex: Male, ECOG PS: ECOG 1, Smoking PY: 0, Smoking Status: Non-smoker, Ds Site: Nasal Cavity, Subsite: Nasal Vestibule/Septum, T: T1, N: N0, M : M0, Stage: I, Path: Squamous Cell Carcinoma, HPV: none, Tx Modality: RT alone, Chemo? : none, Dose: 60.0, Fx: 25, Local: Yes, Regional: none, Distant: none, 2nd Ca: none, ContrastEnhanced: 1\nAnswer: ",
        "recruit-recruiter": "1. Radiation Oncologist - Your expertise is strictly limited to radiation therapy planning and dosing for head and neck squamous cell carcinoma, especially HPV-negative cases involving the nasal cavity and vestibule. - Hierarchy: Radiation Oncologist",
        "initial_assessment-radiation oncologist": "**Step 1: Initial Assessment (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical spine, base of the skull, oral cavity, pharynx, and airway.\n- The vertebral bodies and intervertebral discs are visible, showing normal alignment without obvious fractures or deformities.\n- The airway appears patent without significant obstruction.\n- The masked region of interest (ROI) is located anteriorly, near the base of the tongue or oropharyngeal region, and is highlighted in two colors (green and brown).\n- The green masked area is relatively small and localized, possibly representing a tumor or pathological lesion.\n- The brown masked area is adjacent and slightly larger, possibly representing involved lymph nodes or an extension of the lesion.\n- No grossly visible calcifications or necrotic areas are noted within the ROI.\n- Surrounding soft tissues appear unremarkable without obvious signs of edema or infiltration.\n\n**Step 2: Mapping Bounding Boxes**\n\n- Bounding box 1: [251, 89, 122, 251, 123, 142]\n  - This box is narrow in the z-axis (251 to 251, likely a single slice), extends from y=89 to 123, and x=122 to 142.\n  - This corresponds spatially to the green masked region near the anterior oropharynx/base of tongue.\n- Bounding box 2: [254, 206, 116, 254, 237, 147]\n  - Also a single slice in z (254), extending from y=206 to 237 and x=116 to 147.\n  - This corresponds to the brown masked region, likely representing a lymph node or adjacent pathological structure in the neck.\n\n**Step 3: Clinical Reasoning**\n\n- Patient likely has a head and neck squamous cell carcinoma (HNSCC) involving the oropharynx or base of tongue region.\n- The green ROI likely represents the primary tumor.\n- The brown ROI likely represents a regional lymph node metastasis or involved nodal basin.\n- The presence of two distinct ROIs suggests at least N1 nodal involvement.\n- The tumor appears localized without gross invasion into adjacent bony structures or airway obstruction.\n- No distant metastases are visible on this scan.\n- The patient may be HPV positive or negative; this is not specified but is important for prognosis.\n- Radiation therapy planning should target both the primary tumor and involved nodal regions with appropriate margins.\n- Dose fractionation and modality should be tailored based on tumor size, nodal involvement, and patient performance status.\n- Prognosis depends on tumor stage, HPV status, and response to therapy.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan shows a localized oropharyngeal squamous cell carcinoma with at least one involved regional lymph node.\n- The masked ROIs correspond to the primary tumor and nodal metastasis.\n- No evidence of distant spread or airway compromise.\n- Radiation therapy should be planned to cover both ROIs with curative intent.\n- Prognosis is cautiously optimistic if HPV positive and treated with definitive radiation +/- chemotherapy.\n- Close follow-up is essential to monitor treatment response and detect recurrence.\n\n---\n\n**Final clinical impression:** Localized oropharyngeal squamous cell carcinoma with nodal involvement, suitable for definitive radiation therapy.\n\n---\n\n**Answer: Alive**",
        "Round 1-role-comment": "radiation oncologist:alive",
        "Round 1-num_agents": 1,
        "Round 2-Turn 1-discuss-participate-radiation oncologist": "No",
        "Round 2-Turn 1-ask_gap-radiation oncologist": "Yes. A diagnostic radiologist or head and neck radiologist is needed to provide a detailed interpretation of the CT scan findings, including tumor extent, nodal involvement, and any subtle anatomical abnormalities. This expertise is essential to complement radiation therapy planning and ensure accurate target delineation. Additionally, a medical oncologist or head and neck surgeon may be helpful for comprehensive treatment planning and multidisciplinary management.",
        "Round 2-Turn 1-gap_identified-assistant": "- Consult a diagnostic radiologist or head and neck radiologist for detailed interpretation of the CT scan findings, including tumor extent, nodal involvement, and subtle anatomical abnormalities to aid accurate target delineation in radiation therapy planning.  \n- Involve a medical oncologist or head and neck surgeon for comprehensive treatment planning and multidisciplinary management.",
        "Round 2-Turn 1-gap_recruit-recruiter": "1. Diagnostic Radiologist (Head and Neck Radiologist) - Your expertise is strictly limited to detailed interpretation of contrast-enhanced CT scans for head and neck cancers, including assessment of tumor extent, nodal involvement, and anatomical details critical for radiation therapy planning. - Hierarchy: Diagnostic Radiologist == Radiation Oncologist\n2. Medical Oncologist - Your expertise is strictly limited to systemic therapy decisions and multidisciplinary treatment planning for head and neck squamous cell carcinoma, including evaluation of the need for chemotherapy or other systemic treatments. - Hierarchy: Medical Oncologist == Radiation Oncologist",
        "Round 2-Turn 1-gap_recruited_assessment-diagnostic radiologist (head and neck radiologist)": "**Step 1: Initial Assessment (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region, focusing on the nasal cavity and anterior skull base.\n- Visible anatomical structures include the nasal septum, nasal vestibule, hard palate, maxillary sinus, and anterior cranial fossa.\n- The cervical spine is visible posteriorly with normal alignment.\n- The airway is patent without obstruction.\n- The masked region of interest (ROI) is located anteriorly in the nasal cavity region, specifically around the nasal vestibule and septum.\n- The green masked area is small and localized, consistent with a primary lesion in the nasal vestibule or septum.\n- The brown masked area is adjacent but slightly larger, possibly representing local soft tissue involvement or early regional spread.\n- No obvious bony destruction or invasion into adjacent sinuses or skull base is noted.\n- No enlarged lymph nodes or distant abnormalities are visible in this limited view.\n\n**Step 2: Mapping Bounding Boxes**\n\n- Bounding box 1: [251, 89, 122, 251, 123, 142]\n  - This corresponds to a narrow slice in the z-axis, covering y=89 to 123 and x=122 to 142.\n  - This spatially maps to the green masked region in the nasal vestibule/septum area, consistent with the primary tumor.\n- Bounding box 2: [254, 206, 116, 254, 237, 147]\n  - Also a single slice in z-axis, covering y=206 to 237 and x=116 to 147.\n  - This corresponds to the brown masked region, likely representing adjacent soft tissue or early local extension, but no clear nodal involvement.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 75-year-old male with a T1N0M0 squamous cell carcinoma of the nasal vestibule/septum.\n- ECOG performance status is 1, indicating relatively preserved functional status.\n- Non-smoker, which may favor better prognosis.\n- The tumor is small and localized without regional nodal or distant metastases.\n- Treatment planned is radiation therapy alone (60 Gy in 25 fractions), appropriate for early-stage disease.\n- No chemotherapy is planned, consistent with early stage and absence of nodal disease.\n- The masked ROIs correspond to the primary tumor and possibly adjacent soft tissue involvement but no nodal disease.\n- Prognosis is favorable given early stage, localized disease, and good performance status.\n- Close follow-up is necessary to monitor for local recurrence.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding box mapping confirm a small, localized squamous cell carcinoma of the nasal vestibule/septum without nodal or distant spread.\n- The masked ROIs correspond to the primary tumor and adjacent soft tissue.\n- Radiation therapy alone is an appropriate curative treatment.\n- Given the patient's clinical profile and tumor stage, survival probability is high.\n\n---\n\n**Final clinical impression:** Early-stage nasal vestibule squamous cell carcinoma, localized, treated with definitive radiation therapy, favorable prognosis.\n\n---\n\nAnswer: Alive",
        "Round 2-Turn 1-gap_recruited_assessment-medical oncologist": "**Step 1: Initial Assessment (without bounding box data)**\n\n- The CT scan is a sagittal view of the head and neck region.\n- Visible anatomical structures include the cervical spine, base of the skull, oral cavity, pharynx, and airway.\n- The vertebral bodies and intervertebral discs show normal alignment without fractures or deformities.\n- The airway is patent without obstruction.\n- The masked region of interest (ROI) is located anteriorly near the oropharyngeal region, with two distinct color-coded areas: green and brown.\n- The green masked area is small and localized, likely representing a primary tumor.\n- The brown masked area is adjacent and slightly larger, possibly representing a lymph node or extension of the lesion.\n- No obvious necrosis or calcifications within the ROI.\n- Surrounding soft tissues appear normal without edema or infiltration.\n\n**Step 2: Mapping Bounding Boxes**\n\n- Bounding box 1: [251, 89, 122, 251, 123, 142]\n  - Corresponds to the green masked region near the anterior oropharynx/base of tongue, likely the primary tumor.\n- Bounding box 2: [254, 206, 116, 254, 237, 147]\n  - Corresponds to the brown masked region, likely a regional lymph node or adjacent pathological structure.\n\n**Step 3: Clinical Reasoning**\n\n- Patient is a 75-year-old male with a T1N0M0 squamous cell carcinoma of the nasal vestibule/septum.\n- ECOG performance status is 1, indicating relatively preserved functional status.\n- Non-smoker, which is favorable for prognosis.\n- The tumor is small (T1), with no regional (N0) or distant metastases (M0).\n- Treatment planned is radiation therapy alone (60 Gy in 25 fractions), appropriate for early-stage disease.\n- No chemotherapy planned, consistent with early stage and absence of nodal disease.\n- The masked ROI and bounding boxes in the oropharyngeal region do not correspond to the nasal cavity tumor site, suggesting no visible nodal involvement or secondary lesions in this scan.\n- The absence of nodal disease and distant metastases supports a good prognosis.\n- HPV status is negative, which may slightly reduce prognosis compared to HPV-positive tumors but is less relevant in nasal cavity SCC.\n- Radiation therapy alone is standard for early-stage nasal vestibule SCC and is expected to provide good local control.\n\n**Step 4: Integrated Conclusion**\n\n- The CT scan and bounding box data show a localized small squamous cell carcinoma in the nasal vestibule/septum without nodal or distant spread.\n- The masked ROI likely represents the primary tumor with no evidence of nodal involvement.\n- The patient is treated with definitive radiation therapy alone, appropriate for stage I disease.\n- Prognosis is favorable given early stage, good performance status, and absence of smoking history.\n- Close follow-up is necessary to monitor for local recurrence.\n\n---\n\n**Final clinical impression:** Early-stage nasal vestibule squamous cell carcinoma, treated with radiation therapy alone, with favorable prognosis.\n\n---\n\nAnswer: Alive",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-diagnostic radiologist (head and neck radiologist)": "No",
        "Round 2-Turn 1-Round 2-Turn 1-gap_recruited_discuss-participate-medical oncologist": "No",
        "Round 2-role-comment": "radiation oncologist:alive|diagnostic radiologist (head and neck radiologist):alive|medical oncologist:alive",
        "Round 2-num_agents": 3,
        "num_cooperations-panel": 0,
        "decision-Moderator": "('Answer: Alive',)"
    }
}